Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 161
YÖKSİS161 OpenAlex0
Projects 0
Books 0
Proceedings 10

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 147
h-index 19 Percentile in Türkiye: 97 #11 of 1,066 at their university by h-index
i10-index
32
Total citations
16,120
Top 0.1% in Türkiye
Per article
109.7
FWCI
6.46
1.00 = world average
World top 1%
7
World top 10%
12

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 157
  • Q1 88 %56.1
  • Q2 44 %28.0
  • Q3 23 %14.6
  • Q4 2 %1.3
WoS (JCR) 159
  • Q1 56 %35.2
  • Q2 28 %17.6
  • Q3 27 %17.0
  • Q4 48 %30.2
TR Index 4 articles
OpenAlex citation percentile
Top 1%7
Top 10%12
Avg · n 138 %48.1
Other counts

Scopus (SJR)

  • YÖKSİS rows 163

WoS (JCR)

  • YÖKSİS rows 165

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

161articles

Journals with publications

64 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article filter applied. Journal filter: Journal of Clinical Oncology Clear filter ×

Article list

17 / 161 articles

  1. 2016 Triple negative breast cancer: Demographic and clinicopathological properties. Journal of Clinical Oncology DOI 10.1200/JCO.2016.34.15_suppl.e12572 YÖKSİS SJR Q1 JCR Q1
  2. 2016 Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients. Journal of Clinical Oncology DOI 10.1200/JCO.2016.34.15_suppl.e12578 YÖKSİS SJR Q1 JCR Q1
  3. 2016 Treatment of Lymph Node–Negative, Early-Stage HER2-Positive Breast Cancer Journal of Clinical Oncology DOI 10.1200/JCO.2015.63.8411 YÖKSİS SJR Q1 JCR Q1 OpenAlex 52.6%
  4. 2014 Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes. Journal of Clinical Oncology DOI 10.1200/jco.2014.32.15_suppl.1073 YÖKSİS SJR Q1 JCR Q1
  5. 2014 Is there any correlation between molecular subtypes and blood groups in breast cancer? Journal of Clinical Oncology DOI 10.1200/jco.2014.32.15_suppl.e11554 YÖKSİS SJR Q1 JCR Q1
  6. 2011 Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: Baskent University experience. Journal of Clinical Oncology DOI 10.1200/jco.2011.29.15_suppl.e16001 YÖKSİS SJR Q1 JCR Q1
  7. 2010 Cisplatin combination regimen in the second-line treatment of non-small cell lung cancer. Journal of Clinical Oncology DOI 10.1200/jco.2010.28.15_suppl.e18136 YÖKSİS SJR Q1 JCR Q1
  8. 2005 Heparin and CXCL12 Dimerization Journal of Clinical Oncology DOI 10.1200/JCO.2005.02.1444 YÖKSİS SJR Q1 JCR Q1 OpenAlex 61.9%
  9. 2005 Interleukin-6 and C-Reactive Protein in Metastatic Renal Cell Carcinoma Journal of Clinical Oncology DOI 10.1200/JCO.2005.05.155 YÖKSİS SJR Q1 JCR Q1 OpenAlex 51.5%
  10. 2005 Heparanase Activity and Bone Loss in Postmenopausal Breast Cancer Patients Journal of Clinical Oncology DOI 10.1200/JCO.2005.04.0121 YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.1%
  11. 2005 Targeted Therapy for Targeted Patients: Trastuzumab in Adjuvant Treatment of Non\u2013Small-Cell Lung Cancer Journal of Clinical Oncology DOI 10.1200/JCO.2005.05.192 YÖKSİS SJR Q1 JCR Q1 OpenAlex 49.1%
  12. 2005 CA125 Nadir Values As a Prognostic Factor in Epithelial Ovarian Cancer Journal of Clinical Oncology DOI 10.1200/JCO.2005.05.136 YÖKSİS SJR Q1 JCR Q1 OpenAlex 8.8%
  13. 2004 The Field of Radiation Therapy May Effect Health-Related Quality of Life in Patients With Operable Breast Cancer Journal of Clinical Oncology DOI 10.1200/JCO.2004.99.331 YÖKSİS SJR Q1 JCR Q1 OpenAlex 54.1%
  14. 2004 Free Circulating DNA: Good As a Diagnostic Marker in Lung Cancer? Journal of Clinical Oncology DOI 10.1200/JCO.2004.99.020 YÖKSİS SJR Q1 JCR Q1 OpenAlex 58.2%
  15. 2004 Unusual Abdominal Tumors Journal of Clinical Oncology DOI 10.1200/JCO.2004.08.105 YÖKSİS SJR Q1 JCR Q1 OpenAlex 60.6%
  16. 2004 Pamidronate, Hypocalcemia, and Calcium and Vitamin D Supplementation Journal of Clinical Oncology DOI 10.1200/JCO.2004.99.300 YÖKSİS SJR Q1 JCR Q1 OpenAlex 6.1%
  17. 2003 Superiority of Letrozole Over Tamoxifen in the First-Line Treatment of Metastatic Breast Cancer Patients With Normal Serum HER-2/neu Levels: Question of Tamoxifen Resistance Journal of Clinical Oncology DOI 10.1200/JCO.2003.99.152 YÖKSİS SJR Q1 JCR Q1 OpenAlex 8.1%

← Back to academicians